Camber Capital Management

Camber Capital Management as of Sept. 30, 2018

Portfolio Holdings for Camber Capital Management

Camber Capital Management holds 26 positions in its portfolio as reported in the September 2018 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spdr S&p 500 Etf (SPY) 24.9 $581M 2.0M 290.72
Allergan 7.3 $171M 900k 190.48
Hca Holdings (HCA) 6.0 $139M 1.0M 139.12
Mylan Nv 5.9 $137M 3.8M 36.60
Tesaro 5.8 $137M 3.5M 39.01
Universal Health Services (UHS) 4.9 $115M 900k 127.84
Biogen Idec (BIIB) 4.5 $106M 300k 353.31
McKesson Corporation (MCK) 4.3 $100M 750k 132.65
Nektar Therapeutics (NKTR) 3.9 $91M 1.5M 60.96
Global Blood Therapeutics In 3.4 $79M 2.1M 38.00
Momenta Pharmaceuticals 3.2 $76M 2.9M 26.30
Perrigo Company (PRGO) 3.0 $71M 1.0M 70.80
Atara Biotherapeutics (ATRA) 2.9 $67M 1.6M 41.35
Brookdale Senior Living (BKD) 2.7 $64M 6.5M 9.83
Envision Healthcare 2.6 $62M 1.4M 45.73
Medicines Company 2.6 $60M 2.0M 29.91
AMAG Pharmaceuticals 2.3 $53M 2.7M 20.00
Clovis Oncology 2.2 $51M 1.8M 29.37
Tenet Healthcare Corporation (THC) 1.9 $44M 1.6M 28.46
Puma Biotechnology (PBYI) 1.5 $34M 750k 45.85
K2m Group Holdings 1.2 $27M 1.0M 27.37
Zymeworks 0.9 $22M 1.4M 15.70
Eagle Pharmaceuticals (EGRX) 0.9 $20M 292k 69.33
Endologix 0.8 $18M 9.3M 1.91
Sutro Biopharma (STRO) 0.4 $9.0M 600k 15.00
Surgery Partners (SGRY) 0.1 $2.2M 135k 16.50